COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Inactivation of E. faecalis under microwave heat treatment and ultrasound probe
- Abstract Book: Journée Internationale Bioressources au Profit de la Technologie Alimentaire (JIBTA 2021)
- Abstract Book: Séminaire international : « Environnement, Agriculture & Biotechnologie » (SIEAB – 2017)
- Anti-inflammatory activity of doum palm fruit extract used in the management of benign prostatic hyperplasia
- Regional and socio-demographic predictors of dietary proficiency of adolescent girls in Nigeria
- Does sex differ the relationship between macronutrients adequacy and aerobic power?
- Critical evaluation of the discrepancy between whole and refined foods: nutritional implications
- Immune-stimulating and antioxidant properties of a traditional Algerian plant combination: Date fruit (Phoenix dactylifera) and Fenugreek seeds (Trigonella foenum-graecum)
- Breastfeeding knowledge, attitude, and practices among mothers at EPI centers in the Northern part of Dhaka city
- Sex and income level can be determinants for meat attachment behavior among Turkish university students
You may also start an advanced similarity search for this article.

NAJFNR is licensed under